Finally, where sufficient data is available, i.e. enough screened models, the algorithms implemented in CoRe could be used to analyze specific subsets of cancer cell lines hosting certain molecular features (e.g. KRAS mutations in colorectal carcinoma), allowing identifying/comparing subtype specific core-fitness genes, which would be of particular interest for translational cancer research. Here, KRAS is linked to colorectal carcinoma.